Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 2/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8906700 | 1.00 | KMT2A (0.53) | KMT2AMEN1MAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL21633899 | 0.98 | KMT2A (0.51) | KMT2AMEN1MAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL21633900 | 0.98 | KMT2A (0.51) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL31323054 | 0.87 | KMT2A (0.50) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL31322986 | 0.86 | ELANE (0.57) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL11996303 | 0.86 | ELANE (0.57) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL10325206 | 0.84 | KMT2A (0.54) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL18256 | 0.84 | KMT2A (0.54) | KMT2AMEN1MAPTTDP1KDM4E | |
| SCHEMBL6663601 | 0.83 | KMT2A (0.53) | KMT2AMEN1MAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL7736403 | 0.83 | KMT2A (0.53) | KMT2AMEN1MAPTTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024140670-A1 | CONJUGATE AND USES THEREOF | FULL-LIFE TECHNOLOGIES HK LIMITED (CN) | 2024-07-04 | — | — | WO | claimed |
| US-20240174715-A1 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | INDI MOLECULAR, INC. | 2024-05-30 | — | — | US | claimed |
| US-11919972-B2 | Peptide libraries with non-canonical amino acids | REGENERON PHARMACEUTICALS, INC. (US) | 2024-03-05 | — | — | US | claimed |
| WO-2022212698-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS, INC. (US) | 2022-10-06 | — | — | WO | claimed |
| EP-3810169-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | BicycleTX Limited (GB) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243832-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | BICYCLETX LIMITED (GB) | 2019-12-26 | — | — | WO | claimed |
| US-20180085479-A1 | CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE | J. STEFAN INSTITUTE (SI) | 2018-03-29 | — | — | US | claimed |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-10-16 | — | — | US | claimed |
| US-20140227175-A1 | CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE | J. STEFAN INSTITUTE (SI) | 2014-08-14 | — | — | US | claimed |
| EP-2723387-A1 | CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE | J. Stefan Institute (SI) | 2014-04-30 | — | — | EP | claimed |
| US-20050164950-A1 | Orally administered small peptides synergize statin activity | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-07-28 | — | — | US | claimed |
| WO-2005016280-A2 | ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-24 | — | — | WO | claimed |
| US-20040254120-A1 | Orally administered small peptides synergize statin activity | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-16 | — | — | US | claimed |
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | NOVASPIN BIOTECH GMBH (DE) | 2003-06-19 | — | — | US | claimed |
| WO-2002100885-A2 | A PENTA- OR TETRAPEPTIDE BINDING TO SOMATOSTATIN RECEPTORS AND THE USE OF THE SAME | NOVASPIN BIOTECH GMBH (DE) | 2002-12-19 | — | — | WO | claimed |
| US-6232305-B1 | ANTICANCER AGENTS; BONE DISORDERS; ANTIARTHRITIC AGENTS; RESPIRATORY SYSTEM DISORDERS | NAEJA PHARMACEUTICAL INC. (CA) | 2001-05-15 | — | — | US | claimed |
| EP-0961779-A1 | SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (CA) | 1999-12-08 | — | — | EP | claimed |
| CN-1234735-A | Method for treating skin pigmentation | JOHNSON & JOHNSON CONSUMER (US) | 1999-11-10 | — | — | CN | claimed |
| WO-1998032766-A1 | SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (US) | 1998-07-30 | — | — | WO | claimed |
| CN-1156964-A | Novel Peptides | MERCK & CO INC (US) | 1997-08-13 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | FABP4, LIPC, GPR119 | KMT2A 1751/4885MEN1 4525/4885MAPT 1065/4885 |
| US-20240174715-A1 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | ARGLU1, NGLY1, VIP | KMT2A 3792/4885MEN1 296/4885MAPT 4023/4885 |
| US-20140227175-A1 | CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE | CTSB, CTSV, CTSE | KMT2A 3762/4885MEN1 2970/4885MAPT 3277/4885 |
| US-11919972-B2 | Peptide libraries with non-canonical amino acids | ARGLU1, NGLY1, VIP | KMT2A 3792/4885MEN1 296/4885MAPT 4023/4885 |
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | SSTR5, SSTR3, SCTR | KMT2A 4510/4885MEN1 629/4885MAPT 2988/4885 |
| US-20180085479-A1 | CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE | CTSB, CTSV, CTSE | KMT2A 3762/4885MEN1 2970/4885MAPT 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.